Cancer (Tumor) Profiling Market Report

Cancer (Tumor) Profiling Market - Global Professional Analysis and Forecast to 2026

  • POSTDATE：Mar 04, 2020
  • PAGES：192
  • REPORT CODE：GMM494157
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The worldwide Cancer (Tumor) Profiling market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.1% during the forecast period.

    This report presents the market size and development trends by detailing the Cancer (Tumor) Profiling market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Cancer (Tumor) Profiling market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Cancer (Tumor) Profiling industry and will help you to build a panoramic view of the industrial development.

    Cancer (Tumor) Profiling Market, By Type:

    • Immunoassay

    • Hybridization

    • NGS

    • Mass Spectrometry

    Cancer (Tumor) Profiling Market, By Application:

    • Clinical

    • Research

    Some of the leading players are as follows:

    • Helomics Corporation.

    • Illumina, Inc

    • Nanostring Technologies, Inc

    • HTG Molecular Diagnostics, Inc.

    • Qiagen NV

    • Qiagen N.V.

    • Neogenomics Laboratories, Inc.

    • Genomic Health Inc.

    • Caris Life Sciences.

    • Ribomed Biotechnologies, Inc.

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Methodology and Scope

    • 1.1 Market Segmentation & Scope

      • 1.1.1 Technology Type

      • 1.1.2 Product

      • 1.1.3 Application

      • 1.1.4 Regional scope

      • 1.1.5 Estimates and forecast timeline

    • 1.2 Research Methodology

    • 1.3 Information Procurement

      • 1.3.1 Purchased database

      • 1.3.2 Internal database

      • 1.3.3 Secondary sources

      • 1.3.4 Primary research

      • 1.3.5 Details of primary research

    • 1.4 Information or Data Analysis

      • 1.4.1 Data analysis models

    • 1.5 Market Formulation & Validation

    • 1.6 Model Details

      • 1.6.1 Commodity flow analysis

      • 1.6.2 Volume price analysis

    • 1.7 List of Secondary Sources

    • 1.8 List of Abbreviations

    2 Executive Summary

    • 2.1 Market Outlook

    • 2.2 Segment Outlook

    3 Market Variables, Trends, & Scope

    • 3.1 Market Lineage Outlook

    • 3.1.1 Parent market outlook

      • 3.1.2 Ancillary market outlook

    • 3.2 Market Segmentation

      • 3.2.1 Analysis

    • 3.3 Market Dynamics

      • 3.3.1 Market driver analysis

      • 3.3.2 Market restraint analysis

      • 3.3.3 Industry opportunities

    • 3.4 Penetration & Growth Prospect Mapping

      • 3.4.1 Penetration & growth prospect mapping analysis

    • 3.5 Business Environment Analysis Tools

      • 3.5.1 Porter's five forces analysis

      • 3.5.2 PESTLE analysis

      • 3.5.3 Major deals & strategic alliances analysis

    4 Cancer (Tumor) Profiling Market: Technology Type Analysis

    • 4.1 Cancer (Tumor) Profiling Technology Type Market Share Analysis, 2018 & 2026

    • 4.2 Cancer (Tumor) Profiling Technology Type Market: Segment Dashboard

    • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

      • 4.3.1 Immunoassay

      • 4.3.2 Hybridization

      • 4.3.3 NGS

      • 4.3.4 Mass Spectrometry

    5 Cancer (Tumor) Profiling Market: Product Analysis

    • 5.1 Cancer (Tumor) Profiling Product Market Share Analysis, 2018 & 2026

    • 5.2 Cancer (Tumor) Profiling Product Market: Segment Dashboard

    • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

    6 Cancer (Tumor) Profiling Market: Application Analysis

    • 6.1 Cancer (Tumor) Profiling Application Market Share Analysis, 2018 & 2026

    • 6.2 Cancer (Tumor) Profiling Application Market: Segment Dashboard

    • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

      • 6.3.1 Clinical

      • 6.3.2 Research

    7 Cancer (Tumor) Profiling Market: Regional Analysis

    • 7.1 Cancer (Tumor) Profiling Regional Market Share Analysis, 2018 & 2026

    • 7.2 Cancer (Tumor) Profiling Regional Market: Segment Dashboard

    • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

    • 7.4 List of Players at Regional Level

      • 7.4.1 North America

      • 7.4.2 Europe

      • 7.4.3 Asia Pacific

    • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

      • 7.5.1 North America

      • 7.5.2 Europe

      • 7.5.3 Asia Pacific

      • 7.5.4 Latin America

      • 7.5.5 MEA

    • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

      • 7.6.1 North America

      • 7.6.2 Europe

      • 7.6.3 Asia Pacific

      • 7.6.4 Latin America

      • 7.6.5 Middle East & Africa

    8 Competitive Analysis

    • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

    • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

    • 8.3 Vendor Landscape

      • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

    9 Company Profiles

    • 9.1 Helomics Corporation.

      • 9.1.1 Helomics Corporation. Company overview

      • 9.1.2 Financial performance

      • 9.1.3 Product benchmarking

      • 9.1.4 Strategic initiatives

      • 9.1.5 SWOT analysis

    • 9.2 Illumina, Inc

      • 9.2.1 Illumina, Inc Company overview

      • 9.2.2 Financial performance

      • 9.2.3 Product benchmarking

      • 9.2.4 Strategic initiatives

      • 9.2.5 SWOT analysis

    • 9.3 Nanostring Technologies, Inc

      • 9.3.1 Nanostring Technologies, Inc Company overview

      • 9.3.2 Financial performance

      • 9.3.3 Product benchmarking

      • 9.3.4 Strategic initiatives

      • 9.3.5 SWOT analysis

    • 9.4 HTG Molecular Diagnostics, Inc.

      • 9.4.1 HTG Molecular Diagnostics, Inc. Company overview

      • 9.4.2 Financial performance

      • 9.4.3 Product benchmarking

      • 9.4.4 Strategic initiatives

      • 9.4.5 SWOT analysis

    • 9.5 Qiagen NV

      • 9.5.1 Qiagen NV Company overview

      • 9.5.2 Financial performance

      • 9.5.3 Product benchmarking

      • 9.5.4 Strategic initiatives

      • 9.5.5 SWOT analysis

    • 9.6 Qiagen N.V.

      • 9.6.1 Qiagen N.V. Company overview

      • 9.6.2 Financial performance

      • 9.6.3 Product benchmarking

      • 9.6.4 Strategic initiatives

      • 9.6.5 SWOT analysis

    • 9.7 Neogenomics Laboratories, Inc.

      • 9.7.1 Neogenomics Laboratories, Inc. Company overview

      • 9.7.2 Financial performance

      • 9.7.3 Product benchmarking

      • 9.7.4 Strategic initiatives

      • 9.7.5 SWOT analysis

    • 9.8 Genomic Health Inc.

      • 9.8.1 Genomic Health Inc. Company overview

      • 9.8.2 Financial performance

      • 9.8.3 Product benchmarking

      • 9.8.4 Strategic initiatives

      • 9.8.5 SWOT analysis

    • 9.9 Caris Life Sciences.

      • 9.9.1 Caris Life Sciences. Company overview

      • 9.9.2 Financial performance

      • 9.9.3 Product benchmarking

      • 9.9.4 Strategic initiatives

      • 9.9.5 SWOT analysis

    • 9.10 Ribomed Biotechnologies, Inc.

      • 9.10.1 Ribomed Biotechnologies, Inc. Company overview

      • 9.10.2 Financial performance

      • 9.10.3 Product benchmarking

      • 9.10.4 Strategic initiatives

      • 9.10.5 SWOT analysis

     

    The List of Tables and Figures (Totals 74 Figures and 147 Tables)

    • Figure Immunoassay Cancer (Tumor) Profiling market, 2015 - 2026 (USD Million)

    • Figure Hybridization Cancer (Tumor) Profiling market, 2015 - 2026 (USD Million)

    • Figure NGS Cancer (Tumor) Profiling market, 2015 - 2026 (USD Million)

    • Figure Mass Spectrometry Cancer (Tumor) Profiling market, 2015 - 2026 (USD Million)

    • Figure Clinical market, 2015 - 2026 (USD Million)

    • Figure Research market, 2015 - 2026 (USD Million)

    • Table List of players in North America

    • Table List of players in Europe

    • Table List of players in Asia Pacific

    • Table SWOT analysis

    • Table North America Cancer (Tumor) Profiling market, by country, 2015 - 2026 (USD Million)

    • Table North America Cancer (Tumor) Profiling market, by type, 2015 - 2026 (USD Million)

    • Table North America Cancer (Tumor) Profiling market, by product, 2015 - 2026 (USD Million)

    • Table North America Cancer (Tumor) Profiling market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.S. Cancer (Tumor) Profiling market, by type, 2015 - 2026 (USD Million)

    • Table U.S. Cancer (Tumor) Profiling market, by product, 2015 - 2026 (USD Million)

    • Table U.S. Cancer (Tumor) Profiling market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Canada Cancer (Tumor) Profiling market, by type, 2015 - 2026 (USD Million)

    • Table Canada Cancer (Tumor) Profiling market, by product, 2015 - 2026 (USD Million)

    • Table Canada Cancer (Tumor) Profiling market, by application, 2015 - 2026 (USD Million)

    • Table Europe Cancer (Tumor) Profiling market, by country, 2015 - 2026 (USD Million)

    • Table Europe Cancer (Tumor) Profiling market, by type, 2015 - 2026 (USD Million)

    • Table Europe Cancer (Tumor) Profiling market, by product, 2015 - 2026 (USD Million)

    • Table Europe Cancer (Tumor) Profiling market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.K. Cancer (Tumor) Profiling market, by type, 2015 - 2026 (USD Million)

    • Table U.K. Cancer (Tumor) Profiling market, by product, 2015 - 2026 (USD Million)

    • Table U.K. Cancer (Tumor) Profiling market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Germany Cancer (Tumor) Profiling market, by type, 2015 - 2026 (USD Million)

    • Table Germany Cancer (Tumor) Profiling market, by product, 2015 - 2026 (USD Million)

    • Table Germany Cancer (Tumor) Profiling market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table France Cancer (Tumor) Profiling market, by type, 2015 - 2026 (USD Million)

    • Table France Cancer (Tumor) Profiling market, by product, 2015 - 2026 (USD Million)

    • Table France Cancer (Tumor) Profiling market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Italy Cancer (Tumor) Profiling market, by type, 2015 - 2026 (USD Million)

    • Table Italy Cancer (Tumor) Profiling market, by product, 2015 - 2026 (USD Million)

    • Table Italy Cancer (Tumor) Profiling market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Spain Cancer (Tumor) Profiling market, by type, 2015 - 2026 (USD Million)

    • Table Spain Cancer (Tumor) Profiling market, by product, 2015 - 2026 (USD Million)

    • Table Spain Cancer (Tumor) Profiling market, by application, 2015 - 2026 (USD Million)

    • Table Asia Pacific Cancer (Tumor) Profiling market, by country, 2015 - 2026 (USD Million)

    • Table Asia Pacific Cancer (Tumor) Profiling market, by type, 2015 - 2026 (USD Million)

    • Table Asia Pacific Cancer (Tumor) Profiling market, by product, 2015 - 2026 (USD Million)

    • Table Asia Pacific Cancer (Tumor) Profiling market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table China Cancer (Tumor) Profiling market, by type, 2015 - 2026 (USD Million)

    • Table China Cancer (Tumor) Profiling market, by product, 2015 - 2026 (USD Million)

    • Table China Cancer (Tumor) Profiling market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Japan Cancer (Tumor) Profiling market, by type, 2015 - 2026 (USD Million)

    • Table Japan Cancer (Tumor) Profiling market, by product, 2015 - 2026 (USD Million)

    • Table Japan Cancer (Tumor) Profiling market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table India Cancer (Tumor) Profiling market, by type, 2015 - 2026 (USD Million)

    • Table India Cancer (Tumor) Profiling market, by product, 2015 - 2026 (USD Million)

    • Table India Cancer (Tumor) Profiling market, by application, 2015 - 2026 (USD Million)

    • Table Latin America Cancer (Tumor) Profiling market, by country, 2015 - 2026 (USD Million)

    • Table Latin America Cancer (Tumor) Profiling market, by type, 2015 - 2026 (USD Million)

    • Table Latin America Cancer (Tumor) Profiling market, by product, 2015 - 2026 (USD Million)

    • Table Latin America Cancer (Tumor) Profiling market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Brazil Cancer (Tumor) Profiling market, by type, 2015 - 2026 (USD Million)

    • Table Brazil Cancer (Tumor) Profiling market, by product, 2015 - 2026 (USD Million)

    • Table Brazil Cancer (Tumor) Profiling market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Mexico Cancer (Tumor) Profiling market, by type, 2015 - 2026 (USD Million)

    • Table Mexico Cancer (Tumor) Profiling market, by product, 2015 - 2026 (USD Million)

    • Table Mexico Cancer (Tumor) Profiling market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Argentina Cancer (Tumor) Profiling market, by type, 2015 - 2026 (USD Million)

    • Table Argentina Cancer (Tumor) Profiling market, by product, 2015 - 2026 (USD Million)

    • Table Argentina Cancer (Tumor) Profiling market, by application, 2015 - 2026 (USD Million)

    • Table MEA Cancer (Tumor) Profiling market, by country, 2015 - 2026 (USD Million)

    • Table MEA Cancer (Tumor) Profiling market, by type, 2015 - 2026 (USD Million)

    • Table MEA Cancer (Tumor) Profiling market, by product, 2015 - 2026 (USD Million)

    • Table MEA Cancer (Tumor) Profiling market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table South Africa Cancer (Tumor) Profiling market, by type, 2015 - 2026 (USD Million)

    • Table South Africa Cancer (Tumor) Profiling market, by product, 2015 - 2026 (USD Million)

    • Table South Africa Cancer (Tumor) Profiling market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Nigeria Cancer (Tumor) Profiling market, by type, 2015 - 2026 (USD Million)

    • Table Nigeria Cancer (Tumor) Profiling market, by product, 2015 - 2026 (USD Million)

    • Table Nigeria Cancer (Tumor) Profiling market, by application, 2015 - 2026 (USD Million)

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Company market position analysis

    • Table Company Profiles

    • Table Helomics Corporation. Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Illumina, Inc Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Nanostring Technologies, Inc Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table HTG Molecular Diagnostics, Inc. Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Qiagen NV Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Qiagen N.V. Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Neogenomics Laboratories, Inc. Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Genomic Health Inc. Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Caris Life Sciences. Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Ribomed Biotechnologies, Inc. Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US